VOCO® St. John’s Solihull
651 Warwick Road
Solihull
B91 1AT
IBD Doctors National Meeting 2022
"Looking Beyond Guidelines - Putting the Best into Practice"
The Scientific Faculty and Ferring Pharmaceuticals are delighted to invite you to The National IBD Doctors Annual Meeting 2022. The meeting will take place from the evening of 22nd to the afternoon of the 23rd September 2022 at the VOCO® St. John’s Hotel in Solihull, 651 Warwick Road, B91 1AT.
Travel and accommodation costs will be covered for all registered delegates by Ferring Pharmaceuticals. The forum spaces are limited so please register early to secure your place by visiting https://bit.ly/DrsIBDMeeting.
Once your place is secured, you will receive a confirmation email.
This meeting is organised and fully funded by Ferring Pharmaceuticals Ltd. Ferring Pharmaceuticals Ltd. have had no input into the content of this meeting.
Agenda
September 22, 2022
September 23, 2022
Speakers
Dr Chris Lamb
Consultant Gastroenterologist, The Royal Victoria Hospital, Newcastle
Dr Gareth Parkes
Consultant Gastroenterologist, Royal London Hospital, London
Dr Tim Raine
Consultant Gastroenterologist, Addenbrooke’s Hospital, Cambridge
Dr Hannah Gordon
Gastroenterology Specialist Registrar, Bart’s Health NHS Trust, London
Professor Jimmy Limdi
Consultant Gastroenterologist, The Northern Care Alliance NHS Foundation Trust, Manchester
Dr Neeraj Bhala
Consultant Physician and Gastroenterologist, Queen Elizabeth Hospital and University Hospital Birmingham NHS Foundation Trust
Dr Rohit Rao
Consultant Gastroenterologist, Bart’s Health NHS Trust, London
Dr Krisztina Gecse
Consultant Gastroenterologist, Amsterdam University Medical Centre, Netherlands
Ms Laura Hancock
Consultant General and Colorectal Surgeon, Manchester University NHS Foundation Trust
Alicia Sandall
Guy’s and St Thomas’ NHS Foundation Trust, London
Meet the FacultyClick faculty images for biographies
Dr Gareth Parkes
Gareth trained at Cambridge, Bart’s & the London and studied for a PhD at King’s College London, examining the role of the gut bacteria in the development of irritable bowel syndrome. He now works as a Consultant Gastroenterologist at the Royal London Hospital where he is a core member of the IBD team. His interests include Irritable Bowel Syndrome (IBS), Crohn’s disease, Ulcerative Colitis, probiotics and low FODMAP diets in IBS as well as indigestion and heartburn. Gareth sits on the British Society of Gastroenterology IBD committee, has a number of publications in the field of IBS and IBD and reviews papers for Alimentary Pharmacology & Therapeutics (APT), Neurogastromotility and the Annals of Gastroenterology. He is actively involved as a chief investigator in commercial clinical trials and has developed the UK’s first mobile phone App for patients with IBD ‐ ‘My IBD Care’.
Dr Chris Lamb
Chris Lamb is an academic gastroenterologist working as an Honorary Consultant in Gastroenterology at the Newcastle upon Tyne Hospitals NHS Foundation Trust and a Clinical Intermediate Fellow at Newcastle University. A former NIHR Clinical Lecturer and previous Wellcome Trust Clinical Fellow in Translational Medicine and Therapeutics he has a clinical and research specialist interest in inflammatory bowel disease.
Chris leads a mucosal immunology research programme that studies biological signatures of inflammation aiming to inform existing treatment stratification, the development of novel, or repurposing of existing therapies, and innovative clinical trial design to benefit patients through contributing to precision medicine strategies. In addition he has an interest in evidence synthesis and for the last 3 years along with a multidisciplinary group of UK IBD clinicians and patients he has led the development of the British Society of Gastroenterology (BSG) guidelines on management of IBD in adults. Chris is a previous recipient of the award Young Gastroenterologist of the Year: Emerging Leader from the BSG, and was previously awarded the BSG President’s medal by Sir Ian Gilmore. He is a current member of the IBD Section of the BSG and has previously Chaired the Trainees Section Committee, and been a member of the Training Committee, Education Committee and Council of the BSG.
Dr Tim Raine
Tim Raine is a consultant gastroenterologist and clinical lead for IBD at Addenbrooke’s Hospital, Cambridge, UK. Tim is a member of the ECCO (European Crohn’s and Colitis Organisation) guidelines committee, and an author and group leader on several current ECCO guidelines. He serves on the British Society of Gastroenterology (BSG) IBD Clinical Research Group and was awarded BSG Young Gastroenterologist of the Year 2016. Tim has an interest in clinical trials and is lead investigator of several studies including the major UK IASO trial in acute-severe colitis. His research, funded by the Wellcome Trust, CCFA, OpenTargets and the National Institute for Health Research, focuses on regulation of the gastrointestinal immune system. Tim is an honorary faculty member of the Wellcome Trust Sanger Centre, UK.
Gareth trained at Cambridge, Bart’s & the London and studied for a PhD at King’s College London, examining the role of the gut bacteria in the development of irritable bowel syndrome. He now works as a Consultant Gastroenterologist at the Royal London Hospital where he is a core member of the IBD team. His interests include Irritable Bowel Syndrome (IBS), Crohn’s disease, Ulcerative Colitis, probiotics and low FODMAP diets in IBS as well as indigestion and heartburn. Gareth sits on the British Society of Gastroenterology IBD committee, has a number of publications in the field of IBS and IBD and reviews papers for Alimentary Pharmacology & Therapeutics (APT), Neurogastromotility and the Annals of Gastroenterology. He is actively involved as a chief investigator in commercial clinical trials and has developed the UK’s first mobile phone App for patients with IBD ‐ ‘My IBD Care’.
Chris Lamb is an academic gastroenterologist working as an Honorary Consultant in Gastroenterology at the Newcastle upon Tyne Hospitals NHS Foundation Trust and a Clinical Intermediate Fellow at Newcastle University. A former NIHR Clinical Lecturer and previous Wellcome Trust Clinical Fellow in Translational Medicine and Therapeutics he has a clinical and research specialist interest in inflammatory bowel disease.
Chris leads a mucosal immunology research programme that studies biological signatures of inflammation aiming to inform existing treatment stratification, the development of novel, or repurposing of existing therapies, and innovative clinical trial design to benefit patients through contributing to precision medicine strategies. In addition he has an interest in evidence synthesis and for the last 3 years along with a multidisciplinary group of UK IBD clinicians and patients he has led the development of the British Society of Gastroenterology (BSG) guidelines on management of IBD in adults. Chris is a previous recipient of the award Young Gastroenterologist of the Year: Emerging Leader from the BSG, and was previously awarded the BSG President’s medal by Sir Ian Gilmore. He is a current member of the IBD Section of the BSG and has previously Chaired the Trainees Section Committee, and been a member of the Training Committee, Education Committee and Council of the BSG.
Tim Raine is a consultant gastroenterologist and clinical lead for IBD at Addenbrooke’s Hospital, Cambridge, UK. Tim is a member of the ECCO (European Crohn’s and Colitis Organisation) guidelines committee, and an author and group leader on several current ECCO guidelines. He serves on the British Society of Gastroenterology (BSG) IBD Clinical Research Group and was awarded BSG Young Gastroenterologist of the Year 2016. Tim has an interest in clinical trials and is lead investigator of several studies including the major UK IASO trial in acute-severe colitis. His research, funded by the Wellcome Trust, CCFA, OpenTargets and the National Institute for Health Research, focuses on regulation of the gastrointestinal immune system. Tim is an honorary faculty member of the Wellcome Trust Sanger Centre, UK.
